Kenya National Cancer Control Programme (NCCP) Implementation Guide
1.0.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: Kenya OCM Protocol Markers Code System

Official URL: https://fhir.dha.go.ke/terminology/CodeSystem/ocm-protocol-markers-cs Version: 1.0.0
Active as of 2026-08-18 Computable Name: OCMProtocolMarkersCS

Biomarker and molecular marker codes used for treatment protocol selection.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system https://fhir.dha.go.ke/terminology/CodeSystem/ocm-protocol-markers-cs defines the following codes:

CodeDisplayDefinition
HER2-POSITIVE HER2 Positive HER2/neu overexpression or amplification detected.
HER2-NEGATIVE HER2 Negative No HER2/neu overexpression or amplification.
ER-POSITIVE ER Positive Oestrogen receptor positive.
ER-NEGATIVE ER Negative Oestrogen receptor negative.
PR-POSITIVE PR Positive Progesterone receptor positive.
PR-NEGATIVE PR Negative Progesterone receptor negative.
TRIPLE-NEGATIVE Triple Negative ER-, PR-, HER2- breast cancer.
KRAS-MUTANT KRAS Mutant KRAS mutation detected.
KRAS-WILD-TYPE KRAS Wild-type No KRAS mutation.
BRAF-V600E BRAF V600E Mutant BRAF V600E mutation detected.
PD-L1-POSITIVE PD-L1 Positive PD-L1 expression ≥1%.
PD-L1-NEGATIVE PD-L1 Negative PD-L1 expression <1%.
MSI-HIGH MSI-High Microsatellite instability high.
MSI-LOW MSI-Low / MSS Microsatellite instability low or stable.
EGFR-MUTANT EGFR Mutant EGFR mutation detected.
ALK-POSITIVE ALK Positive ALK rearrangement detected.
NOT-TESTED Not Tested Biomarker testing not performed.

Description of the above table(s).